Barcoded AAV Vector Assessment at Single Cell Resolution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing transduction efficiency and specificity of gene delivery vectors, such as adeno-associated virus (AAV) serotypes, are limited by low throughput and resolution, particularly when dealing with heterogeneous cell populations, leading to inaccurate identification of optimal vectors for therapeutic use.
Innovation Solution
A method involving the use of barcoded AAV vectors that are transduced into heterogeneous cell populations, followed by single-cell sequencing to identify the presence of each vector at the cellular level, allowing for high-throughput analysis of transduction efficiency and specificity across different cell types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If bulk sequencing methods are used to assess transduction efficiency, then throughput is improved, but measurement precision at single-cell level deteriorates
Solution Approach 1:
The patent partitions the heterogeneous cell population into individual single cells before sequencing. Each cell is processed separately through reverse transcription and PCR amplification, allowing precise identification of which specific cell received which vector. This segmentation enables both high throughput (by processing many cells in parallel) and single-cell resolution (by analyzing each cell individually), resolving the contradiction between bulk throughput and cellular precision.
2Device complexity
If traditional transduction assessment methods are used, then device complexity is reduced, but transduction specificity detection capability deteriorates
Solution Approach 1:
The patent uses unique barcodes associated with specific AAV vectors that can be detected in individual cells. By examining the local quality (presence/absence of specific barcodes) in each cell, the method achieves high transduction specificity detection. The barcode sequences allow precise identification of which vector transduced which cell, enabling detailed specificity analysis without requiring overly complex experimental setups.
Solution Approach 2:
The patent introduces barcode sequences as intermediary markers that link specific AAV vectors to the cells they transduce. These barcodes serve as detectable intermediaries that allow researchers to track vector delivery without directly observing the transduction process itself. The barcodes are incorporated into the vector genome and can be amplified and detected through standard molecular biology techniques, simplifying the overall detection methodology.
3Measurement precision
If high-resolution single-cell analysis is performed, then transduction efficiency measurement accuracy is improved, but productivity deteriorates
Solution Approach 1:
The patent performs preliminary actions by partitioning cells into individual compartments and adding unique molecular identifiers (UMIs) and barcodes during the reverse transcription step. This preliminary tagging of each cell's RNA before amplification allows for efficient tracking and quantification later. By establishing this identification system early in the workflow, the patent enables high-throughput processing of many cells while maintaining single-cell resolution accuracy in the final analysis.
Solution Approach 2:
The patent uses PCR amplification to create multiple copies of the barcode sequences and cDNA from each single cell. This copying process amplifies the signal from the tiny amount of starting material in a single cell, making it detectable and quantifiable. The amplification allows high-throughput processing because many cells can be processed in parallel, yet each cell's unique barcode identity is preserved and can be accurately counted to determine transduction efficiency with single-cell precision.
Data Source
AI summary
Disclosed is a method for assessing the transduction efficiency and/or specificity of vectors at single cell level.